Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease
- 1 January 2016
- book chapter
- Published by Elsevier
- p. 387-413
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Cerebrovascular disease, beta-amyloid, and cognition in agingNeurobiology of Aging, 2012
- Caveolin-1 is required for vascular endothelial insulin uptakeAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- When neurogenesis encounters aging and diseaseTrends in Neurosciences, 2010
- Sirt3-Mediated Deacetylation of Evolutionarily Conserved Lysine 122 Regulates MnSOD Activity in Response to StressMolecular Cell, 2010
- Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stressDiabetologia, 2010
- Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinicThe Lancet Neurology, 2009
- In Skeletal Muscle Advanced Glycation End Products (AGEs) Inhibit Insulin Action and Induce the Formation of Multimolecular Complexes Including the Receptor for AGEsJournal of Biological Chemistry, 2008
- Severity of diabetic microvascular complications is associated with a low soluble RAGE levelDiabetes & Metabolism, 2008
- Endothelial dysfunction in diabetesBritish Journal of Pharmacology, 2000
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996